‹ Return to Disorder Directory

Dyssynergia Cerebellaris Myoclonica

Description

Dyssynergia Cerebellaris Myoclonica refers to a collection of rare, degenerative, neurological disorders characterized by epilepsy, cognitive impairment, myoclonus, and progressive ataxia.  Symptoms include seizures, tremor, and reduced muscle coordination.  Onset of the disorder generally occurs in early adulthood.  Tremor may begin in one extremity and later spread to involve the entire voluntary muscular system.  Arms are usually more affected than legs.  Some of the cases are due to mitochondrial abnormalities.

Treatment

Treatment of Dyssynergia Cerebellaris Myoclonica is symptomatic.  Myoclonus and seizures may be treated with drugs like valproate.

Prognosis

The progression of the disorder is usually 10 years or longer.

Research

The NINDS supports a broad range of research on neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica.  The goals of this research are to find ways to prevent, treat, and cure these kinds of disorders. Information from the National Library of Medicine’s MedlinePlusCerebellar Disorders



Information sourced through CNF’s partnership with The National Institute of Neurological Disorders and Stroke (NINDS), US National Institutes of Health.